Materialise NV Adds Euronext Brussels Listing
Ticker: MTLS · Form: 6-K · Filed: Nov 18, 2025 · CIK: 1091223
| Field | Detail |
|---|---|
| Company | Materialise NV (MTLS) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: listing, stock-exchange, prospectus
Related Tickers: MTLS
TL;DR
Materialise NV is adding a Euronext Brussels listing to its Nasdaq listing, expanding European access.
AI Summary
On November 18, 2025, Materialise NV announced the publication of a Listing Prospectus in relation to the additional listing of its ordinary shares on Euronext Brussels. This listing will complement its existing listing of American depositary shares (ADSs) on the Nasdaq. The prospectus was prepared and disseminated in accordance with applicable European Union and Belgian laws and regulations.
Why It Matters
This dual listing on Euronext Brussels and Nasdaq aims to broaden Materialise's investor base and enhance its visibility in European markets.
Risk Assessment
Risk Level: low — The filing is a routine announcement regarding a stock exchange listing and does not contain significant financial or operational risks.
Key Players & Entities
- Materialise NV (company) — Registrant
- Euronext Brussels (company) — Stock Exchange
- Nasdaq (company) — Stock Exchange
- November 18, 2025 (date) — Publication Date
FAQ
What is the purpose of the Listing Prospectus published by Materialise NV?
The Listing Prospectus was published in relation to the additional listing of Materialise NV's ordinary shares on Euronext Brussels.
On which stock exchanges are Materialise NV's shares or ADSs listed?
Materialise NV's ordinary shares will be additionally listed on Euronext Brussels, complementing the existing listing of its American depositary shares (ADSs) on the Nasdaq.
When was the Listing Prospectus published?
The Listing Prospectus was published on November 18, 2025.
What type of securities are being listed on Euronext Brussels?
Ordinary shares of Materialise NV are being additionally listed on Euronext Brussels.
Under which laws and regulations was the Listing Prospectus prepared?
The Listing Prospectus was prepared and disseminated pursuant to applicable European Union and Belgian laws and regulations.
Filing Stats: 218 words · 1 min read · ~1 pages · Grade level 15.8 · Accepted 2025-11-18 16:50:29
Filing Documents
- tm2531609d1_6k.htm (6-K) — 10KB
- tm2531609d1_ex99-1.htm (EX-99.1) — 2066KB
- tm2531609d1_ex99-1img001.jpg (GRAPHIC) — 5KB
- tm2531609d1_ex99-1sp2img001.jpg (GRAPHIC) — 138KB
- 0001104659-25-113702.txt ( ) — 2276KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-36515 Materialise NV Technologielaan 15 3001 Leuven Belgium (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F On November 18, 2025, Materialise NV (the “Company” or “Materialise”) published a prospectus dated as of even date (the “Listing Prospectus”), prepared and disseminated by the Company pursuant to applicable European Union and Belgian laws and regulations, in relation to its additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares (ADSs) representing ordinary shares. A copy of the Listing Prospectus is attached hereto as Exhibit 99.1. EXHIBIT INDEX Exhibit Description 99.1 Listing Prospectus dated November 18, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MATERIALISE NV By: /s/ Brigitte de Vet-Veithen Name: Brigitte de Vet-Veithen De Vet Management BV Title: Chief Executive Officer Date: November 18, 2025